SARS-CoV-2 infection or vaccination; a trio of tests from EUROIMMUN
EUROIMMUN UK supplies the healthcare industry with medical diagnostic products in the principal areas of autoimmunity, infectious diseases and allergy.
EUROIMMUN UK is the British subsidiary of the EUROIMMUN group, a manufacturer of medical laboratory diagnostic products. EUROIMMUN was one of the first companies in the world to offer a comprehensive panel of SARS-CoV-2 tests, validated for in vitro diagnostic purposes.
Tests offered by EUROIMMUN include direct detection methods and highly accurate indirect detection methods to assess the immune response following SARS-CoV-2 infection or vaccination. The latest assays developed by the company are the Anti-SARS-CoV-2 QuantiVac (IgG), the SARS-CoV-2 NeutraLISA and the SARS-CoV-2 IGRA.
EUROIMMUN UK has supported public health bodies in establishing a serology assay for use in the National Testing Strategy since March 2020, especially for the serosurveillance study, the results of which have informed the UK government’s strategy to combat the pandemic.